Infection with the human immunodeficiency virus type 1 (HIV-1), as demonstrated by viral cultures, has been described in some patients before antibodies to HIV-1 can be detected, but the duration and frequency of such latent infections are uncertain. We selected prospectively a cohort of 133 seronegative homosexual men who continued to be involved in high-risk sexual activity, and we cultured 225 samples of their peripheral-blood lymphocytes, using mitogen stimulation to activate the integrated HIV-1 genome. HIV-1 was isolated in blood samples from 31 of the 133 men (23 percent), 27 of whom have remained seronegative for up to 36 months after the positive culture. The other four men seroconverted 11 to 17 months after the isolation of HIV-1. In three of them, we studied cryopreserved lymphocytes obtained earlier, using the polymerase chain reaction to amplify small amounts of viral DNA, and we demonstrated that HIV-1 provirus had been present 23, 35, and 35 months before seroconversion. We conclude that HIV-1 infection in homosexual men at high risk may occur at least 35 months before antibodies to HIV-1 can be detected. A prolonged period of latency in such infections may be more common than previously recognized; the degree of infectiousness during such periods is unknown.
Source Information
Department of Pediatrics, University of California at Los Angeles, School of Medicine, Torrance 90509.
This article has been cited by other articles:
Koning, F. A., van der Vorst, T. J. K., Schuitemaker, H.
(2005). Low Levels of Human Immunodeficiency Virus Type 1 DNA in High-Risk Seronegative Men. J. Virol.
79: 6551-6553
[Abstract][Full Text]
Drosten, C., Muller-Kunert, E., Dietrich, M., Gerdes, J., Schmitz, H.
(2005). Topographic and Quantitative Display of Integrated Human Immunodeficiency Virus-1 Provirus DNA in Human Lymph Nodes by Real-Time Polymerase Chain Reaction. J. Mol. Diagn.
7: 219-225
[Abstract][Full Text]
Zhu, T., Corey, L., Hwangbo, Y., Lee, J. M., Learn, G. H., Mullins, J. I., McElrath, M. J.
(2003). Persistence of Extraordinarily Low Levels of Genetically Homogeneous Human Immunodeficiency Virus Type 1 in Exposed Seronegative Individuals. J. Virol.
77: 6108-6116
[Abstract][Full Text]
Klein, H. G.
(2000). Will Blood Transfusion Ever Be Safe Enough?. JAMA
284: 238-240
[Full Text]
McChesney, M. B., Collins, J. R., Lu, D., Lu, X., Torten, J., Ashley, R. L., Cloyd, M. W., Miller, C. J.
(1998). Occult Systemic Infection and Persistent Simian Immunodeficiency Virus (SIV)-Specific CD4+-T-Cell Proliferative Responses in Rhesus Macaques That Were Transiently Viremic after Intravaginal Inoculation of SIV. J. Virol.
72: 10029-10035
[Abstract][Full Text]
Litvak, E., Siegel, J. E., Pauker, S. G., Lallemant, M., Fineberg, H. V., Weinstein, M. C.
(1997). Whose Blood Is Safer?: The Effect of the Stage of the Epidemic on Screening for HIV. Med Decis Making
17: 455-463
[Abstract]
Bryson, Y. J., Pang, S., Wei, L. S., Dickover, R., Diagne, A., Chen, I. S.Y.
(1995). Clearance of HIV Infection in a Perinatally Infected Infant. NEJM
332: 833-838
[Abstract][Full Text]
Blumberg, M., Langston, D.
(1991). Mandatory HIV Testing in Criminal Justice Settings. Crime Delinquency
37: 5-18
[Abstract]
Blumberg, M.
(1990). The Transmission Of HIV: Exploring Some Misconceptions Related to Criminal Justice. Criminal Justice Policy Review
4: 288-305
[Abstract]
Mariner, W. K.
(1990). The Ethical Conduct of Clinical Trials of HIV Vaccines. Eval Rev
14: 538-564
[Abstract]
(1989). HIV INFECTION IN SERONEGATIVE GAY MEN. JWatch General
1989: 1-1
[Full Text]
Previous
